Surface protein distribution in Group B Streptococcus isolates from South Africa and identifying vaccine targets through in silico analysis
Authors:
Open Access
- 30 September 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-17
Abstract
Group B Streptococcus (GBS) is a major cause of pneumonia, sepsis, and meningitis in infants younger than 3 months of age. Furthermore, GBS infection in pregnant women is associated with stillbirths and pre-term delivery. It also causes disease in immunocompromised adults and the elderly, but the highest incidence of the disease occurs in neonates and young infants. At this time, there are no licensed vaccines against GBS. Complete GBS genome sequencing has helped identify genetically conserved and immunogenic proteins, which could serve as vaccine immunogens. In this study, in silico reverse vaccinology method were used to evaluate the prevalence and conservation of GBS proteins in invasive and colonizing isolates from South African infants and women, respectively. Furthermore, this study aimed to predict potential GBS vaccine targets by evaluating metrics such as antigenicity, physico-chemical properties, subcellular localization, secondary and tertiary structures, and epitope prediction and conservation. A total of 648 invasive and 603 colonizing GBS isolate sequences were screened against a panel of 89 candidate GBS proteins. Ten of the 89 proteins were highly genetically conserved in invasive and colonizing GBS isolates, nine of which were computationally inferred proteins (gbs2106, SAN_1577, SAN_0356, SAN_1808, SAN_1685, SAN_0413, SAN_0990, SAN_1040, SAN_0226) and one was the surface Immunogenic Protein (SIP). Additionally, the nine proteins were predicted to be more antigenic than the SIP protein (antigenicity score of > 0.6498), highlighting their potential as GBS vaccine antigen targets.Keywords
This publication has 76 references indexed in Scilit:
- Jalview Version 2—a multiple sequence alignment editor and analysis workbenchBioinformatics, 2009
- Preventing Bacterial Infections with Pilus-Based Vaccines: the Group B Streptococcus ParadigmThe Journal of Infectious Diseases, 2009
- T lymphocytes in acute bacterial infection: increased prevalence of CD11b+ cells in the peripheral blood and recruitment to the infected siteImmunology, 2008
- Vaccine-induced pathogen strain replacement: what are the mechanisms?Journal of The Royal Society Interface, 2007
- Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteomeNature Biotechnology, 2006
- Characterization of a Novel Leucine-Rich Repeat Protein Antigen from Group B Streptococci That Elicits Protective ImmunityInfection and Immunity, 2005
- Presentation of Endogenously Synthesized MHC Class II-Restricted Epitopes by MHC Class II Cancer Vaccines Is Independent of Transporter Associated with Ag Processing and the ProteasomeThe Journal of Immunology, 2005
- Surface Proteins ofStreptococcus agalactiaeand Related Proteins in Other Bacterial PathogensClinical Microbiology Reviews, 2005
- A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogenJournal of Clinical Investigation, 2003
- Identification of Group B Streptococcal Sip Protein, Which Elicits Cross-Protective ImmunityInfection and Immunity, 2000